Dataset from Multicenter, Open-label, Ascending Dose Study of BIBR 1048 in the Prevention of Venous Thromboembolism in Patients Undergoing Primary Elective Total Hip Replacement Surgery. Bistro I
收藏NIAID Data Ecosystem2026-05-02 收录
数据链接：
官方服务：
资源简介：
- To determine the therapeutic window of BIBR 1048 in order to select doses for further studies in the development plan. - Twice daily regimen will be tested for most dose levels and once daily administration will also be evaluated when appropriate.
创建时间：
2025-02-22
